Cargando…
Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report
An 80-year-old Japanese male patient with Behçet’s disease presented with a seven-day history of fever, cough, and progressive shortness of breath after receiving a second dose of the BNT16B2b2 mRNA COVID-19 vaccine (Pfizer-BioNTech). The initial diagnosis was community-acquired pneumonia, and antib...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of British Infection Association.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533633/ https://www.ncbi.nlm.nih.gov/pubmed/36212609 http://dx.doi.org/10.1016/j.clinpr.2022.100204 |
_version_ | 1784802386131288064 |
---|---|
author | Kojima, Yuichi Takeyabu, Kimihiro Satoh, Miki Konno, Satoshi |
author_facet | Kojima, Yuichi Takeyabu, Kimihiro Satoh, Miki Konno, Satoshi |
author_sort | Kojima, Yuichi |
collection | PubMed |
description | An 80-year-old Japanese male patient with Behçet’s disease presented with a seven-day history of fever, cough, and progressive shortness of breath after receiving a second dose of the BNT16B2b2 mRNA COVID-19 vaccine (Pfizer-BioNTech). The initial diagnosis was community-acquired pneumonia, and antibiotic treatment was started but proved ineffective. Twenty days after onset, his platelet count was significantly decreased. We suspected vaccine-induced pneumonitis and thrombocytopenia. After administration of prednisolone and intravenous immunoglobulin, and platelet transfusions, his platelet count normalized. The pneumonia symptoms improved three weeks after onset. Herein, we also summarize previous reports of cases of pneumonitis and thrombocytopenia associated with SARS-CoV-2 vaccination. |
format | Online Article Text |
id | pubmed-9533633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Ltd on behalf of British Infection Association. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95336332022-10-05 Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report Kojima, Yuichi Takeyabu, Kimihiro Satoh, Miki Konno, Satoshi Clin Infect Pract Case Reports and Series An 80-year-old Japanese male patient with Behçet’s disease presented with a seven-day history of fever, cough, and progressive shortness of breath after receiving a second dose of the BNT16B2b2 mRNA COVID-19 vaccine (Pfizer-BioNTech). The initial diagnosis was community-acquired pneumonia, and antibiotic treatment was started but proved ineffective. Twenty days after onset, his platelet count was significantly decreased. We suspected vaccine-induced pneumonitis and thrombocytopenia. After administration of prednisolone and intravenous immunoglobulin, and platelet transfusions, his platelet count normalized. The pneumonia symptoms improved three weeks after onset. Herein, we also summarize previous reports of cases of pneumonitis and thrombocytopenia associated with SARS-CoV-2 vaccination. The Authors. Published by Elsevier Ltd on behalf of British Infection Association. 2022-11 2022-10-05 /pmc/articles/PMC9533633/ /pubmed/36212609 http://dx.doi.org/10.1016/j.clinpr.2022.100204 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Reports and Series Kojima, Yuichi Takeyabu, Kimihiro Satoh, Miki Konno, Satoshi Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report |
title | Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report |
title_full | Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report |
title_fullStr | Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report |
title_full_unstemmed | Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report |
title_short | Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report |
title_sort | thrombocytopenia and pneumonitis associated with bnt16b2b2 mrna covid-19 vaccine: a case report |
topic | Case Reports and Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533633/ https://www.ncbi.nlm.nih.gov/pubmed/36212609 http://dx.doi.org/10.1016/j.clinpr.2022.100204 |
work_keys_str_mv | AT kojimayuichi thrombocytopeniaandpneumonitisassociatedwithbnt16b2b2mrnacovid19vaccineacasereport AT takeyabukimihiro thrombocytopeniaandpneumonitisassociatedwithbnt16b2b2mrnacovid19vaccineacasereport AT satohmiki thrombocytopeniaandpneumonitisassociatedwithbnt16b2b2mrnacovid19vaccineacasereport AT konnosatoshi thrombocytopeniaandpneumonitisassociatedwithbnt16b2b2mrnacovid19vaccineacasereport |